The phrase "agents and tools" is correct and usable in written English.
It can be used in contexts discussing various entities or instruments involved in a process or system, such as in technology, business, or research.
Example: "In our study, we analyzed the effectiveness of different agents and tools in improving productivity."
Alternatives: "actors and instruments" or "participants and resources".
Mejdrova, I. et al. Rational Design of Novel Highly Potent and Selective Phosphatidylinositol 4-Kinase IIIbeta (PI4KB) Inhibitors as Broad-Spectrum Antiviral Agents and Tools for Chemical Biology.
Rational approaches for the design of enzyme inhibitors furnish powerful strategies for developing pharmaceutical agents and tools for probing biological mechanisms.
Due to the key role of DNA in cell life and pathological processes, the design of specific chemical nucleases, DNA probes and alkylating agents is an important research area for the development of new therapeutic agents and tools in Biochemistry.
Antibody-based strategies are emerging as potent therapies as the small size of scFv intrabodies facilitates their delivery to subcellular compartments, making them suitable as therapeutic agents and tools for the study of conformational disorders (35).
Selective inhibitors of protein tyrosine phosphatases (PTPases) are of great interest as therapeutic agents and research tools.
PA1, PA25, and related polyamides offer promise as antiviral agents and as tools to regulate HPV episomal levels in cells for the study of HPV biology.
Traditional dendrimers possess unique cascade-branched structural properties that allow for multivalent modifications with drug cargos, targeting/delivery agents and imaging tools.
Growing buyer independence is requiring less work of traditional agents—and the tools they utilize.
Speci cally, ATAL addresses issues such as th- ries of agency, software architectures for intelligent agents, methodologies and programming languages for realizing agents, and software tools for developing and evaluating agent systems.
Speci cally, ATAL - dresses issues of theories of agency, software architectures for intelligent agents, methodologies and programming languages for realizing agents, and software tools for applying and evaluating agent-based systems.
Therefore, and in spite of their undeniable success, only a small proportion of patients do actually benefit from antiangiogenic agents, and reliable tools to prospectively identify which patients are more likely to benefit are scarce.
